Diligence memo · auto-generated · as of July 3, 2026

Renaissance Physicians Accountable Care LLC

Renaissance Physicians Accountable Care LLC looks over-valued against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Renaissance Physicians Accountable Care LLC operates in Hospitals and Physicians, based in HOUSTON.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Renaissance Physicians Accountable Care LLC has raised $546K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $546K on 2017-10-31.

Most recent recorded round closed around 2017-10-31.

Valuation (modeled)modeled

Provath models Renaissance Physicians Accountable Care LLC at approximately $16M (range $356K–$177M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Over-valued. Modeled value is 1.82× the median modeled value of Pre-Seed Hospitals and Physicians companies in 2016–2018 (39 peers) — value vs value, same stage and era. Issuer reports no revenue, yet is modeled well above niche peers.

Financing rhythm & timingmixed

Last raise 8.7 yr ago; this sector typically re-raises about every 12 months.

Only one round on record and long silent — often defunct, acquired, or gone quiet.

Comparablesmixed

Capital scale ranks ahead of 22% of Hospitals and Physicians peers (599 compared).

Modeled value ranks above 42% of those peers.

Closest niche peers: Oriental Dolphins CCG II Lender LLP, Grand View Surgery Center at Harleysville, LLC, St. Luke's Surgery Center of Chesterfield, LLC, Summit Medical Group, LLC, Riverview Surgical Center, Llc.

Peoplefiled

8 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

Modeled above niche peers — valuation risk on entry.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.